Archives for December 2013
by: Lynn A. Toops, Attorney
The FDA recently announced a proposed rule change to make manufacturers of antibacterial soap prove that these products work as advertised. This move comes after research studies have indicated that Triclosan, a common active ingredient in antibacterial products, is no more effective than soap and water at ridding of germs and it might be dangerous. A concern is that many of these antibacterial soap makers advertise that their products are more effective than soap and water.
In November, the FDA announced it would begin the process of changing its rules to allow generic drug manufacturers the ability to update product labels with safety warnings and new information. This action follows much debate about the responsibility of generic drug manufacturers in patient-safety matters.